JYNT
The Joint Corp.NASDAQHealthcare$8.60+2.91%ClosedMarket Cap: $127.8M
As of 2026-04-06
Valuation
P/E (TTM)
43.98
PEG
0.33
P/B
8.56
P/S
2.40
EV/EBITDA
97.31
DCF Value
$2.67
FCF Yield
0.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
76.6%
Operating Margin
-1.6%
Net Margin
5.3%
ROE
14.4%
ROA
4.8%
ROIC
-3.2%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $15.2M | 70.6% | $750.3K | $991.1K | $0.07 | — |
| FY 2025 | $54.9M | 76.6% | $-905.5K | $2.9M | $0.19 | — |
| Q3 2025 | $13.4M | 80.1% | $160.9K | $855.0K | $0.06 | — |
| Q2 2025 | $13.3M | 79.1% | $-1.1M | $93.4K | $0.01 | — |
| Q1 2025 | $13.1M | 77.3% | $-678.5K | $967.8K | $0.05 | — |
| Q4 2024 | $-38.3M | 108.2% | $3.8M | $-2.7M | $-0.18 | — |
| FY 2024 | $52.2M | 77.9% | $-1.9M | $-5.8M | $-0.56 | — |
| Q3 2024 | $30.2M | 90.7% | $-3.2M | $-3.2M | $-0.21 | — |
| Q2 2024 | $12.6M | 77.7% | $-1.8M | $-3.6M | $-0.24 | — |
| Q1 2024 | $12.2M | 77.8% | $-426.6K | $947.0K | $0.06 | — |
| Q4 2023 | $30.6M | 90.6% | $-147.4K | $-11.0M | $-0.75 | — |
| FY 2023 | $47.0M | 77.7% | $318.3K | $-9.8M | $-0.66 | — |